The ECTRIMS Podcast

Patient Community Day 2025 set a new attendance record, highlighting the growing desire among people living with MS to connect with experts leading the charge in understanding the disease and advancin...

15 Okt 202521min

Can damaged myelin be repaired in people living with multiple sclerosis? Results from the CCMR-Two clinical trial presented at ECTRIMS 2025 offered promising new evidence for remyelination using a com...

2 Okt 202525min

What were the biggest developments in multiple sclerosis treatment at ECTRIMS 2025? As the 41st Congress came to a close in Barcelona, attention turned to new clinical trial results and what they coul...

26 Sep 202516min

What were some of the most important new developments in multiple sclerosis research and treatment at ECTRIMS 2025? Dr. Barry Singer, Director and Founder of The MS Center for Innovations in Care, joi...

25 Sep 202520min

The 41st Congress of ECTRIMS opened in Barcelona with Professor Maria Pia Amato of the University of Florence delivering the ECTRIMS Lecture. In this conversation with host Brett Drummond, she highlig...

24 Sep 202523min

Direct from Barcelona, listen to Alvaro Cobo Calvo from the Multiple Sclerosis Center of Catalonia (Cemcat) and host Brett Drummond discuss the highlights of ECTRIMS 2025 Pre-Day, which is focused on ...

23 Sep 202517min

The 2024 Revisions of the McDonald Diagnostic Criteria for MS have been published in The Lancet Neurology. What do these changes mean for clinical practice? In this episode, we are joined by two autho...

19 Sep 202520min

Genetics not only influence the risk of developing multiple sclerosis (MS), but also affect how the disease progresses and how patients respond to different treatments. Professor Philip De Jager, Chie...

8 Sep 202527min